We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

62 hedge funds and large institutions have $302M invested in Intellia Therapeutics in 2016 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+62
Holders Change %
–
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
62
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$140M
2
O
OrbiMed
New York
+$70.8M
3
BBA
Baker Bros. Advisors
New York
+$28.3M
4
Temasek Holdings
Temasek Holdings
Singapore
+$21M
5
FCMI
Foresite Capital Management III
California
+$20.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$553K +$689K +25,900 New
WCM
27
Wildcat Capital Management
New York
$534K +$665K +25,000 New
SIM
28
Spark Investment Management
New York
$497K +$620K +23,290 New
Charles Schwab
29
Charles Schwab
California
$486K +$605K +22,754 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$462K +$575K +21,626 New
AllianceBernstein
31
AllianceBernstein
Tennessee
$433K +$540K +20,300 New
TCIM
32
TIAA CREF Investment Management
New York
$430K +$535K +20,125 New
MIM
33
Monashee Investment Management
Massachusetts
$425K – – –
SG Americas Securities
34
SG Americas Securities
New York
$374K +$466K +17,509 New
SG
35
Societe Generale
$374K +$466K +17,509 New
PA
36
Perceptive Advisors
New York
$320K +$399K +15,000 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$313K +$390K +14,643 New
Marshall Wace
38
Marshall Wace
United Kingdom
$244K +$304K +11,408 New
TA
39
Teachers Advisors
New York
$235K +$292K +10,990 New
SSA
40
Schonfeld Strategic Advisors
New York
$223K +$278K +10,443 New
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$190K +$236K +8,886 New
Deutsche Bank
42
Deutsche Bank
Germany
$168K +$211K +7,932 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$154K +$192K +7,200 New
NIT
44
NumerixS Investment Technologies
British Columbia, Canada
$117K +$146K +5,500 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$102K +$127K +4,783 New
GP
46
GLG Partners
United Kingdom
$100K +$125K +4,697 New
NFA
47
Nationwide Fund Advisors
Ohio
$97K +$121K +4,539 New
AIG
48
American International Group
New York
$85.8K +$107K +4,020 New
CLOS
49
Compagnie Lombard Odier SCmA
Switzerland
$64K +$79.8K +3,000 New
BlackRock
50
BlackRock
New York
$53K +$65.6K +2,464 New
1
2
3

NTLA Hedge Fund Activity: Q2 2016 in Review

62 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q2 2016, worth a combined $302M.

Buyers outnumbered sellers: 62 funds opened new NTLA positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $140M.

  • 62 institutional investors held Intellia Therapeutics (NTLA) as of Q2 2016, up from 0 in Q1 2016.
  • Funds reported $302M of Intellia Therapeutics stock for Q2 2016.
  • 62 funds opened new Intellia Therapeutics positions in Q2 2016 and 0 closed out, a net change of +62 holders.
  • The largest Intellia Therapeutics buyer in Q2 2016 was Fidelity Investments, an estimated $140M added.

Based on aggregated 13F filings for Q2 2016.